Evidence map›Paper›PMID 32256787›Full record

ArticleExperimental and therapeutic medicine2020

TlR2 and TlR4 are involved in the treatment of rheumatoid arthritis synovial fibroblasts with a medicated serum of asarinin through inhibition of T

Qiaomei Dai, Yaozhang Li, Meiqiao Wang, Yang Li, Ji Li

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Bioflavonoid Robinin fromNutrients · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qiaomei DaiDepartment of Pathology, Heilongjiang University of Chinese Medicine, Xiangfang, Harbin 150040, P.R. China.
Yaozhang LiDepartment of Pathology, Heilongjiang University of Chinese Medicine, Xiangfang, Harbin 150040, P.R. China.
Meiqiao WangDepartment of Pathology, Heilongjiang University of Chinese Medicine, Xiangfang, Harbin 150040, P.R. China.
Yang LiDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, P.R. China.
Ji LiDepartment of Chinese Formulae, Heilongjiang University of Chinese Medicine, Xiangfang, Harbin 150040, P.R. China.
Heilongjiang University of Chinese Medicine · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asarinin is one of the main active chemical components isolated from Xixin, a Chinese medicine. To investigate the role of asarinin in rheumatoid arthritis (RA), the present study investigated the effect of an asarinin-medicated serum on human fibroblast-like synoviocytes

Indexed as

asarininmedicated serumrheumatoid arthritis synovial fibroblastsT helper cell 1T helper cell 17toll-like receptor

Identifiers

PMID32256787
PMCPMC7086207
OpenAlexW3007513420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.